International Journal of Radiation Oncology*Biology*Physics
Clinical investigation: cervixAnemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis
Introduction
The prognostic impact of anemia in cervical cancers is well established. In the comprehensive first report on this topic in 1965, Evans and Bergsjø published results on more than 1000 patients treated for cervical cancers with radiotherapy in the period from 1940 through 1958 at the Radium Hospital in Oslo (1). Patients with a pretreatment hemoglobin (hb) level of less than 11 g/dL had a significantly poorer overall survival as compared with patients with a hb level of 11 g/dL or more. Moreover, Evans and Bergsjø found a more or less linear relationship between low hb levels and reduced survival for anemic patients, e.g., the lower the hb, the higher was the failure rate. Numerous investigations have supported their findings in cervical cancers and other solid tumors 2, 3, 4, 5, 6, 7. In a recent meta-analysis, anemia was found to be an independent prognostic factor for increased death rates also in various solid tumors (head-and-neck, lung, prostate) as well as in lymphomas (8).
As a consequence of the data in cervical cancers, the impact of keeping the hb above 12 g/dL by transfusions has been investigated in a randomized study in the early 1980s at the Princess Margaret Hospital (2). This trial recruited patients with locally advanced cervical cancers treated with definitive radiotherapy. The study showed an advantage in terms of local control for the transfusion group but was stopped after recruiting 132 patients. There was no stratification by tumor volume or stage, and the results of this study have therefore been criticized and are not necessarily a proof that transfusions improve the therapeutic efficacy (9).
Despite the association between anemia and poor prognosis in patients who are treated with definitive radiotherapy for locally advanced cervical cancers, there is no clear evidence whether anemia exerts an independent prognostic impact or whether anemia represents only an epiphenomenon indicating that anemia is linked to adverse prognostic factors such as large tumor volume (9). Moreover, it is unclear how far correcting anemia might impact on prognosis. A recent large retrospective investigation from seven centers in Canada supports the assumption that anemia during radiotherapy is more important than pretreatment hb levels and that there is no difference between spontaneously high hb levels and hb levels after transfusions (10).
Tumor hypoxia offers a possible and attractive radiobiologic explanation for the prognostic impact of anemia. Already in their first report, Evans and Bergsjø discussed an impact of anemia on tumor oxygenation as a cause for increased failure rates in anemic patients (1). Intratumoral hypoxia can be measured with experimental techniques. Höckel et al. demonstrated that hypoxic cervical cancers have a poorer prognosis than better oxygenated tumors 11, 12. Other research groups have confirmed their data, and poor tumor oxygenation has been identified as an independent and major risk factor for treatment failure 13, 14, 15. Poor tumor oxygenation is also associated with an increased risk of nodal disease (16). However, a causative role of hypoxia remains controversial (17).
Angiogenesis has been also identified as a prognostic factor in cervical cancers (18). Most of the clinical investigations have determined angiogenesis by measuring the vascularization grade (microvessel density [MVD]) in histologic specimen as first described by Weidner et al. 19, 20. Highly vascularized tumors (with a high MVD) have in general a poorer prognosis than tumors with lower vascularization.
Our investigation mainly concentrated on the impact of anemia on prognosis and relapse patterns in cervical cancers. Moreover, we investigated the possible relationship between anemia, tumor hypoxia, and angiogenesis.
Section snippets
Patient population
Eighty-seven patients with squamous cell cancer of the cervix underwent prospective evaluation of hypoxia and various prognostic factors in our department in the period between 1995 through 1999. Part of the results with special emphasis on the relation between p53 status and tumor hypoxia have recently been published in this journal (21).
The mean age of the patient population was 58 years (range 35–80 years). All patients were treated with curative intent and followed thereafter in our
Overall survival and patterns of relapse
The overall survival rate for the whole group of patients was 57% after 3 years. The overall survival according to FIGO stage was 72% for Stage IIB, 60% for Stage IIIB, and 22% for Stage IVA. Thus, Stage IVA was a significant risk factor, whereas no significant differences were observed between stages IIB and IIIB.
Thirty-six patients (41%) relapsed. There were 19 local relapses as first site of failure (including patients who were never locally controlled or had a complete remission of less
Discussion
The prognostic impact of anemia in cervical cancers is well established. Nevertheless, the pathophysiologic mechanisms are controversially discussed even in the recent literature. Some retrospective investigations have found an independent impact of anemia on prognosis in multivariate analysis 5, 6, 8, 10, 24. Other researches assume that the prognostic significance of anemia results from an association between anemia and tumor volume and that anemia does not exert an independent impact (9).
Our
References (48)
The significance of anemia in clinical radiation therapy
Int J Radiat Oncol Biol Phys
(1986)- et al.
Pretreatment prognostic factors in carcinoma of the uterine cervixA multivariate analysis of the effect of age, stage, histology, and blood counts on survival
Int J Radiat Oncol Biol Phys
(1983) - et al.
Anemia, hypoxia and transfusion in patients with cervical cancerA review
Radiother Oncol
(2000) - et al.
Oxygenation predicts radiation response and survival in patients with cervix cancer
Radiother Oncol
(1998) - et al.
Treatment outcome in advanced squamous cell carcinoma of the uterine cervixRelationships to pretreatment tumor oxygenation and vascularization
Radiother Oncol
(2000) - et al.
Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix
Radiother Oncol
(1999) - et al.
Tumor size and oxygenation are independent predictors of nodal disease in patients with cervix cancer
Int J Radiat Oncol Biol Phys
(2001) - et al.
Tumor angiogenesis as a prognostic factor in cervical carcinoma
Gynecol Oncol
(1995) - et al.
Tumor hypoxia, p53, and prognosis in cervical cancers
Int J Radiat Oncol Biol Phys
(2001) - et al.
Oxygenation of cervical cancers during radiotherapy and radiotherapy+ cis-retinoic acid/interferon
Int J Radiat Oncol Biol Phys
(1999)
Prognostic value of hemoglobin concentration in radiotherapy for cancer of the supraglottic larynx
Int J Radiat Oncol Biol Phys
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinoma
Int J Radiat Oncol Biol Phys
Intratumoral sickling in a patient with cervix cancer and sickle traitEffect on blood flow and oxygenation
Gynecol Oncol
A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy
Radiother Oncol
Changes in tumor oxygen tension during radiotherapy of uterine cervical cancersRelationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis
Int J Radiat Oncol Biol Phys
Cervix cancer oxygenation measured following external radiation therapy
Int J Radiat Oncol Biol Phys
Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancerA new noninvasive predictive assay
Int J Radiat Oncol Biol Phys
Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
Int J Radiat Oncol Biol Phys
The influence of anemia on the results of radiotherapy in carcinoma of the cervix
Radiology
Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapyResults of a retrospective study of 386 patients
Int J Radiat Oncol Biol Phys
The impact of blood hemoglobin content on the outcome of radiotherapyThe Freiburg experience
Strahlenther Onkol
Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone
Acta Oncol
Significance of hemoglobin concentrations for treatment outcome
Anemia as an independent prognostic factor for survival in patients with cancerA systemic, quantitative review
Cancer
Cited by (147)
Platelet count and MCHC as independent prognostic markers for feline mammary carcinomas
2023, Research in Veterinary ScienceRevisiting the Radical Radiotherapy-Radiochemotherapy Results in Anal Canal Cancers: (TROD Gastrointestinal Group Study 02-005)
2023, Clinical Colorectal CancerIntegration of functional imaging in brachytherapy
2022, Cancer/RadiotherapiePrinciples of radiation therapy and chemotherapy in gynecologic cancer: Basic Principles, Uses, and Complications
2021, Comprehensive GynecologyMultimodal imaging guided brachytherapy: the example of cervical cancer
2019, Cancer/Radiotherapie